British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders

Hurst, John R., Verma, Nisha, Lowe, David, Baxendale, Helen E., Jolles, Stephen, Kelleher, Peter, Longhurst, Hilary J., Patel, Smita Y., Renzoni, Elisabetta A., Sander, Clare R., Avery, Gerard R., Babar, Judith L., Buckland, Matthew S., Burns, Siobhan, Egner, William, Gompels, Mark M., Gordins, Pavels, Haddock, Jamanda A., Hart, Simon P., Hayman, Grant R., Herriot, Richard, Hoyles, Rachel K., Huissoon, Aarnoud P., Jacob, Joseph, Nicholson, Andrew G., Rassl, Doris M., Sargur, Ravishankar B., Savic, Sinisa, Seneviratne, Suranjith L., Sheaff, Michael, Vaitla, Prashantha M., Walters, Gareth I., Whitehouse, Joanna L., Wright, Penny A. and Condliffe, Alison M. 2017. British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. The Journal of Allergy and Clinical Immunology: In Practice 5 (4) , pp. 938-945. 10.1016/j.jaip.2017.01.021

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (309kB) | Preview

Abstract

A proportion of people living with common variable immunodeficiency disorders develop granulomatouslymphocytic interstitial lung disease (GLILD). We aimed to develop a consensus statement on the definition, diagnosis, and management of GLILD. All UK specialist centers were contacted and relevant physicians were invited to take part in a 3-round online Delphi process. Responses were graded as Strongly Agree, Tend to Agree, Neither Agree nor Disagree, Tend to Disagree, and Strongly Disagree, scored D1, D0.5, 0, L0.5, and L1, respectively. Agreement was defined as greater than or equal to 80% consensus. Scores are reported as mean – SD. There was 100% agreement (score, 0.92 – 0.19) for the following definition: “GLILD is a distinct clinico-radio-pathological ILD occurring in patients with [common variable immunodeficiency disorders], associated with a lymphocytic infiltrate and/or granuloma in the lung, and in whom other conditions have been considered and where possible excluded.” There was consensus that the workup of suspected GLILD requires chest computed tomography (CT) (0.98 – 0.01), lung function tests (eg, gas transfer, 0.94 – 0.17), bronchoscopy to exclude infection (0.63 – 0.50), and lung biopsy (0.58 – 0.40). There was no consensus on whether expectant management following optimization of immunoglobulin therapy was acceptable: 67% agreed, 25% disagreed, score 0.38 – 0.59; 90% agreed that when treatment was required, first-line treatment should be with corticosteroids alone (score, 0.55 – 0.51).

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Elsevier
ISSN:	2213-2198
Date of First Compliant Deposit:	8 November 2017
Date of Acceptance:	24 January 2017
Last Modified:	05 May 2023 08:32
URI:	https://orca.cardiff.ac.uk/id/eprint/106264

Citation Data

Cited 87 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item